Sensitivity to chemotherapy is clearly dependent on Myelodysplastic syndromes-leukemia interactions mediated by chemokines such as the SDF-1/CXCR4 axis [40–42], integrins, and E-selectin-mediated adhesion of AML cells to vascular cells [43]. This evidence concerns the gene CXCL12 and acute myeloid leukemia.